{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:00Z","timestamp":1793158140865,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangsu Provincial Key Laboratory of Brain Disease and Bioinformatics Open Research Program","award":["XZSYSKF2023030"],"award-info":[{"award-number":["XZSYSKF2023030"]}]},{"name":"Project of the Affiliated Hospital of Xuzhou Medical University","award":["2023ZY10"],"award-info":[{"award-number":["2023ZY10"]}]},{"name":"Construction Project of High Level Hospital of Jiangsu Province","award":["GSPJS202424"],"award-info":[{"award-number":["GSPJS202424"]}]},{"name":"Advanced Program of the Affiliated Hospital of Xuzhou Medical University","award":["PYJH2024314"],"award-info":[{"award-number":["PYJH2024314"]}]},{"name":"Advanced Program of the Affiliated Hospital of Xuzhou Medical University","award":["PYJH2024316"],"award-info":[{"award-number":["PYJH2024316"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401464"],"award-info":[{"award-number":["82401464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401683"],"award-info":[{"award-number":["82401683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Emerging evidence suggests that gut microbiota and plasma metabolites may be associated with the onset and progression of Parkinson\u2019s disease (PD). The interplay between gut microbiota and plasma metabolites in influencing the progression of cognitive impairment in PD is yet to be fully understood and requires further exploration. Our objective was to investigate the roles of gut microbiota and plasma metabolites in PD cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We initially recruited 100 individuals with PD and 50 healthy controls (HCs). After excluding participants based on education level and cognitive screening criteria, the final cohort comprised 38 PD patients and 40 HCs. We examined fecal and plasma specimens from these participants. Cognitive function was assessed via the Montreal Cognitive Assessment (MoCA). Gut microbiota was analyzed through 16S rRNA sequencing, and plasma metabolites were evaluated via Liquid Chromatography\u2013Mass Spectrometry (LC-MS). Using Spearman correlation to analyze the association between gut microbiota and plasma metabolites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PD patients with mild cognitive impairment (PD-MCI) exhibited distinct microbial and metabolic profiles compared to PD patients with normal cognition (PD-NC). Consistent with both the Gut Microbiota Health Index (GMHI) and Gut Microbiota Health Index (MDI), PD-MCI patients exhibited significant gut microbial dysbiosis. Multi-algorithm differential abundance analysis identified\n                      <jats:italic>g__Eggerthella<\/jats:italic>\n                      as a core depleted genus in PD-MCI, consistently validated across both LEfSe and MaAsLin2 analyses. Additional microbial alterations included depletion of Short-Chain Fatty Acids (SCFA)-producing genera (\n                      <jats:italic>g__Blautia<\/jats:italic>\n                      ,\n                      <jats:italic>g__Lachnoclostridium<\/jats:italic>\n                      ,\n                      <jats:italic>g__Erysipelatoclostridium<\/jats:italic>\n                      ,\n                      <jats:italic>g__norank_f__norank_o__Oscillospirales, g__Megasphaera,<\/jats:italic>\n                      and\n                      <jats:italic>g__Lactococcus<\/jats:italic>\n                      ) and enrichment of\n                      <jats:italic>g__Senegalimassilia<\/jats:italic>\n                      in PD-MCI. Metabolite analysis revealed that phenylalanine metabolism (including phenylacetylglutamine, 2-hydroxycinnamic acid, N-acetyl-L-phenylalanine, and phenylacetylglycine) and PPAR signaling pathways (including 8-hydroxy-5Z,9E,11Z,14Z-eicosatetraenoic acid) were downregulated in the PD-MCI group, while choline metabolism in cancer (including PC(18:1(11Z)\/18:3(6Z,9Z,12Z)) and LysoPC(18:3(6Z,9Z,12Z)\/0:0)) was upregulated. Notably, phenylacetylglutamine demonstrated robust diagnostic potential (AUC\u202f=\u202f0.8222), emerging as a promising biomarker for PD-MCI. Correlation analysis revealed significant associations between key microbial taxa (particularly\n                      <jats:italic>g__Eggerthella<\/jats:italic>\n                      and SCFA-producing genera) and metabolites (phenylacetylglutamine, and uridine 2\u2032,3\u2032-cyclic phosphate), suggesting their interactive role in PD cognitive impairment through gut-brain axis mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our multi-omics study revealed distinct gut microbiota and metabolite alterations in PD patients with cognitive impairment, highlighting gut-brain axis dysfunction. Key microbial and metabolic markers demonstrated diagnostic potential, providing new insights into the pathophysiology of PD-related cognitive decline and potential targets for future therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2025.1667331","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:27:35Z","timestamp":1764570455000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Alterations in gut microbiota and plasma metabolites: a multi-omics study of mild cognitive impairment in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"19","author":[{"given":"Zihao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangdanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"105524","DOI":"10.1016\/j.ecolind.2019.105524","article-title":"The accumulation of species and recovery of species composition along a 70 year succession in a tropical secondary forest","volume":"106","author":"Abbas","year":"2019","journal-title":"Ecol. Indic."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41531-024-00687-1","article-title":"Gut microbiome is not associated with mild cognitive impairment in Parkinson\u2019s disease","volume":"10","author":"Aho","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/s415","article-title":"Parkinson\u2019s disease: a review","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00253-023-12953-y","article-title":"Potassium sodium hydrogen citrate intervention on gut microbiota and clinical features in uric acid stone patients","volume":"108","author":"Cao","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-023-00595-7","article-title":"The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored","volume":"18","author":"Chandra","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.7150\/thno.47289","article-title":"Targeting gut microbiota for precision medicine: focusing on the efficacy and toxicity of drugs","volume":"10","author":"Feng","year":"2020","journal-title":"Theranostics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/bs11050074","article-title":"Cognitive impairment in Parkinson\u2019s disease: epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav. Sci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3390\/cancers12092619","article-title":"Alterations in gastric microbial communities are associated with risk of gastric Cancer in a Korean population: a case-control study","volume":"12","author":"Gunathilake","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1038\/s41467-020-18476-8","article-title":"A predictive index for health status using species-level gut microbiome profiling","volume":"11","author":"Gupta","year":"2020","journal-title":"Nat. Commun."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/jn\/133.10.3187","article-title":"Megasphaera elsdenii JCM1772T normalizes hyperlactate production in the large intestine of fructooligosaccharide-fed rats by stimulating butyrate production","volume":"133","author":"Hashizume","year":"2003","journal-title":"J. Nutr."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000518147","article-title":"Parkinson\u2019s disease and gut microbiota","volume":"77","author":"Hirayama","year":"2021","journal-title":"Ann. Nutr. Metab."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1274925","DOI":"10.3389\/fmicb.2023.1274925","article-title":"Exploring the role of gut microbiota in advancing personalized medicine","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer\u2019s disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J Alzheimer's Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1111\/ene.15848","article-title":"Associations between gut microbiota and Parkinson disease: a bidirectional mendelian randomization analysis","volume":"30","author":"Jiang","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.tim.2016.02.015","article-title":"Oscillospira: a central, enigmatic component of the human gut microbiota","volume":"24","author":"Konikoff","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuron.2012.12.040","article-title":"Environmental novelty activates \u03b22-adrenergic signaling to prevent the impairment of hippocampal LTP by a\u03b2 oligomers","volume":"77","author":"Li","year":"2013","journal-title":"Neuron"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","article-title":"Blautia-a new functional genus with potential probiotic properties?","volume":"13","author":"Liu","year":"2021","journal-title":"Gut Microbes"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","article-title":"Multivariable association discovery in population-scale meta-omics studies","volume":"17","author":"Mallick","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3389\/fimmu.2018.01832","article-title":"Butyrate and dietary soluble Fiber improve neuroinflammation associated with aging in mice","volume":"9","author":"Matt","year":"2018","journal-title":"Front. Immunol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.3390\/ijms25137441","article-title":"The protective effect of uridine in a rotenone-induced model of Parkinson\u2019s disease: the role of the mitochondrial ATP-dependent Potassium Channel","volume":"25","author":"Mironova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3748\/wjg.v22.i25.5742","article-title":"Gut dysfunction in Parkinson\u2019s disease","volume":"22","author":"Mukherjee","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"628459","DOI":"10.1101\/2024.12.13.628459","article-title":"MaAsLin 3: refining and extending generalized multivariable linear models for meta-omic association discovery","volume":"13","author":"Nickols","year":"2024","journal-title":"bioRxiv"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000545478","article-title":"Decreased Lactococcus lactis and propionic acid in Feces of patients with moyamoya disease: possible implications of immune dysregulation","author":"Otomo","year":"2025","journal-title":"Cerebrovasc. Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1037\/neu0000336","article-title":"The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: effects across tasks and developmental stages","volume":"31","author":"Romani","year":"2017","journal-title":"Neuropsychology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e009972","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","article-title":"Gut microbiota-generated phenylacetylglutamine and heart failure","volume":"16","author":"Romano","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1021\/ac9606463","article-title":"Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine","volume":"68","author":"Shockcor","year":"1996","journal-title":"Anal. Chem."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mds.27233","article-title":"Global scales for cognitive screening in Parkinson\u2019s disease: critique and recommendations","volume":"33","author":"Skorvanek","year":"2018","journal-title":"Mov. Disord."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"106969","DOI":"10.1016\/j.ymgme.2022.106969","article-title":"The impact of metabolic control on cognition, neurophysiology, and well-being in PKU: a systematic review and meta-analysis of the within-participant literature","volume":"138","author":"Thomas","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"100992","DOI":"10.1016\/j.ymgmr.2023.100992","article-title":"Professional activity, gender and disease-related emotions: the impact on parents\u2019 experiences in caring for children with phenylketonuria","volume":"36","author":"Walkowiak","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1039\/c9an01642b","article-title":"Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies","volume":"144","author":"Wild","year":"2019","journal-title":"Analyst"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2174\/1570159X21666221019115716","article-title":"Relationship between gut Bacteria and levodopa metabolism","volume":"21","author":"Xu","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s11064-023-04047-y","article-title":"Contrasting Iron metabolism in undifferentiated versus differentiated MO3.13 oligodendrocytes via IL-1\u03b2-induced Iron regulatory protein 1","volume":"49","author":"Yang","year":"","journal-title":"Neurochem. Res."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/acn3.52047","article-title":"A multi-omics study to monitor senescence-associated secretory phenotypes of Alzheimer\u2019s disease","volume":"11","author":"Yang","year":"","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.31083\/j.jin2206157","article-title":"Research Progress of microbiota-gut-brain Axis in Parkinson\u2019s disease","volume":"22","author":"Zhang","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"ref41","first-page":"124","article-title":"Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients","volume":"32","author":"Zimmerman","year":"1989","journal-title":"Clin. Nephrol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1667331\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:27:40Z","timestamp":1764570460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1667331\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":41,"alternative-id":["10.3389\/fnins.2025.1667331"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1667331","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1667331"}}